Lybrate India Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
as on 06-07-2024
- Paid Up Capital ₹ 1.10 Cr
as on 06-07-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 14.89%
(FY 2022)
- Profit -97.89%
(FY 2022)
- Ebitda -60.59%
(FY 2022)
- Net Worth 1.21%
(FY 2022)
- Total Assets 4.42%
(FY 2022)
About Lybrate India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chaman Pardesi and Saurabh Arora serve as directors at the Company.
- CIN/LLPIN
U74140HR2014FTC052854
- Company No.
052854
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
25 Jul 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Lybrate India Private Limited offer?
Lybrate India Private Limited offers a wide range of products and services, including Ind Chem, Extra Mileage Booster, Ayur, Stone Syrup, Herbal Foods Beverages, Ayurvedic Erectile Dysfunction Supplement, Leucorrhoea Herbal Capsule, Herbal Uterine Capsule.
Who are the key members and board of directors at Lybrate India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chaman Pardesi  | Director | 25-Jul-2014 | Current |
| Saurabh Arora | Director | 25-Jul-2014 | Current |
Financial Performance and Corporate Structure Insights of Lybrate India.
Lybrate India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.89% increase. The company also saw a substantial fall in profitability, with a 97.89% decrease in profit. The company's net worth moved up by a moderate rise of 1.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lybrate India?
In 2022, Lybrate India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lybrate India?
Lybrate India has a workforce of 116 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lybrate India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lybrate India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
